Open Access
Erlotinib and the Risk of Oral Cancer
Jama OncologyPeer ReviewedWilliam N. William +232015Journals
Standard molecularly based strategies to predict and/or prevent oral cancer development in patients with oral premalignant lesions (OPLs) are lacking.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support